AirSculpt Technologies (NASDAQ:AIRS) Major Shareholder Purchases $56,100.00 in Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett purchased 30,000 shares of the firm’s stock in a transaction dated Wednesday, March 4th. The stock was purchased at an average cost of $1.87 per share, for a total transaction of $56,100.00. Following the acquisition, the insider owned 6,352,611 shares of the company’s stock, valued at approximately $11,879,382.57. This trade represents a 0.47% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, March 3rd, Jorey Chernett bought 80,000 shares of AirSculpt Technologies stock. The stock was acquired at an average price of $1.71 per share, for a total transaction of $136,800.00.

AirSculpt Technologies Trading Up 5.8%

AIRS traded up $0.10 during trading on Wednesday, hitting $1.84. 448,173 shares of the stock traded hands, compared to its average volume of 608,136. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.51 and a quick ratio of 0.51. The firm has a market capitalization of $114.58 million, a P/E ratio of -6.12 and a beta of 2.75. AirSculpt Technologies, Inc. has a 12-month low of $1.51 and a 12-month high of $12.00. The firm has a 50-day moving average of $2.21 and a 200 day moving average of $4.91.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on AIRS shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AirSculpt Technologies in a research report on Monday, December 29th. Leerink Partners restated a “market perform” rating and set a $6.00 price objective on shares of AirSculpt Technologies in a report on Tuesday, November 11th. One research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Reduce” and an average target price of $6.00.

Hedge Funds Weigh In On AirSculpt Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AIRS. Caitong International Asset Management Co. Ltd bought a new position in shares of AirSculpt Technologies in the fourth quarter valued at approximately $155,000. Aristides Capital LLC acquired a new position in shares of AirSculpt Technologies in the 4th quarter valued at $140,000. Virtu Financial LLC purchased a new position in shares of AirSculpt Technologies in the fourth quarter worth approximately $30,000. XTX Topco Ltd raised its stake in AirSculpt Technologies by 265.2% during the 4th quarter. XTX Topco Ltd now owns 179,813 shares of the company’s stock valued at $356,000 after purchasing an additional 130,581 shares during the period. Finally, Tudor Investment Corp ET AL acquired a new position in AirSculpt Technologies during the fourth quarter valued at $219,000. 91.54% of the stock is owned by institutional investors.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.